To test whether CRP lowering can have beneficial effects in the management of acute kidney injury and in patients receiving kidney transplants, a study using CRP transgenic mice compared to wild-type mice explored the effects of inducing ischemia-reperfusion injury in these mice. The gene discussed is CRP; the disease is acute kidney injury.